AAAAAA

   
Results: 1-10 |
Results: 10
PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER
Authors: TOLCHER AW COWAN KH SOLOMON D OGNIBENE F GOLDSPIEL B CHANG R NOONE MH DENICOFF AM BARNES CS GOSSARD MR FETSCH PA BERG SL BALIS FM VENZON DJ OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I CROSSOVER STUDY OF PACLITAXEL WITH R-VERAPAMIL IN PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 14(4), 1996, pp. 1173-1184
PHASE-I STUDY OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN METASTATIC BREAST-CANCER PATIENTS
Authors: TOLCHER AW COWAN KH NOONE MH DENICOFF AM KOHLER DR GOLDSPIEL BR BARNES CS MCCABE M GOSSARD MR ZUJEWSKI J OSHAUGHNESSY JA
Citation: Aw. Tolcher et al., PHASE-I STUDY OF PACLITAXEL IN COMBINATION WITH CYCLOPHOSPHAMIDE AND GRANULOCYTE-COLONY-STIMULATING FACTOR IN METASTATIC BREAST-CANCER PATIENTS, Journal of clinical oncology, 14(1), 1996, pp. 95-102
TRANSFORMING GROWTH-FACTOR-BETA-1 CIRCULATES IN NORMAL HUMAN PLASMA AND IS UNCHANGED IN ADVANCED METASTATIC BREAST-CANCER
Authors: WAKEFIELD LM LETTERIO JJ CHEN T DANIELPOUR D ALLISON RSH PAI LH DENICOFF AM NOONE MH COWAN KH OSHAUGHNESSY JA SPORN MB
Citation: Lm. Wakefield et al., TRANSFORMING GROWTH-FACTOR-BETA-1 CIRCULATES IN NORMAL HUMAN PLASMA AND IS UNCHANGED IN ADVANCED METASTATIC BREAST-CANCER, Clinical cancer research, 1(1), 1995, pp. 129-136
EFFECT OF R-VERAPAMIL ON THE PHARMACOKINETICS OF PACLITAXEL IN WOMEN WITH BREAST-CANCER
Authors: BERG SL TOLCHER A OSHAUGHNESSY JA DENICOFF AM NOONE M OGNIBENE FP COWAN KH BALIS FM
Citation: Sl. Berg et al., EFFECT OF R-VERAPAMIL ON THE PHARMACOKINETICS OF PACLITAXEL IN WOMEN WITH BREAST-CANCER, Journal of clinical oncology, 13(8), 1995, pp. 2039-2042
PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION
Authors: BERG SL COWAN KH BALIS FM FISHERMAN JS DENICOFF AM HILLIG M POPLACK DG OSHAUGHNESSY JA
Citation: Sl. Berg et al., PHARMACOKINETICS OF TAXOL AND DOXORUBICIN ADMINISTERED ALONE AND IN COMBINATION BY CONTINUOUS 72-HOUR INFUSION, Journal of the National Cancer Institute, 86(2), 1994, pp. 143-145
A DOSE INTENSITY STUDY OF FLAC (5-FLUOROURACIL, LEUCOVORIN, DOXORUBICIN, CYCLOPHOSPHAMIDE) CHEMOTHERAPY AND ESCHERICHIA-COLI-DERIVED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED BREAST-CANCER PATIENTS
Authors: OSHAUGHNESSY JA DENICOFF AM VENZON DJ DANFORTH D PIERCE LJ FRAME JN BASTIAN A GHOSH B GOLDSPIEL B MILLER L DORR FA KEEGAN P BENBARUCH N MROSE H NOONE M COWAN KH
Citation: Ja. Oshaughnessy et al., A DOSE INTENSITY STUDY OF FLAC (5-FLUOROURACIL, LEUCOVORIN, DOXORUBICIN, CYCLOPHOSPHAMIDE) CHEMOTHERAPY AND ESCHERICHIA-COLI-DERIVED GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN ADVANCED BREAST-CANCER PATIENTS, Annals of oncology, 5(8), 1994, pp. 709-716
PHASE-I STUDY OF HIGH-DOSE PIROXANTRONE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: SAVARESE DMF DENICOFF AM BERG SL HILLIG M BAKER SP OSHAUGHNESSY JA CHOW C OTTERSON GA BALIS FM POPLACK DG COWAN KH
Citation: Dmf. Savarese et al., PHASE-I STUDY OF HIGH-DOSE PIROXANTRONE WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 11(9), 1993, pp. 1795-1803
PHASE-II STUDY OF FAZARABINE (NSC-281272) IN PATIENTS WITH METASTATICCOLON-CANCER
Authors: BENBARUCH N DENICOFF AM GOLDSPIEL BR OSHAUGHNESSY JA COWAN KH
Citation: N. Benbaruch et al., PHASE-II STUDY OF FAZARABINE (NSC-281272) IN PATIENTS WITH METASTATICCOLON-CANCER, Investigational new drugs, 11(1), 1993, pp. 71-74
ONCOLOGY NURSE AND PHYSICIAN ATTITUDES TOWARD AGGRESSIVE CANCER-TREATMENT
Authors: DAMROSCH S DENICOFF AM STGERMAIN D WELSCH C BLASH JL JACKSON T ETZELMILLER J
Citation: S. Damrosch et al., ONCOLOGY NURSE AND PHYSICIAN ATTITUDES TOWARD AGGRESSIVE CANCER-TREATMENT, Cancer nursing, 16(2), 1993, pp. 107-112
PHARMACOKINETICS OF PIROXANTRONE IN A PHASE-I TRIAL OF PIROXANTRONE AND GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: BERG SL SAVARESE DMF BALIS FM DENICOFF AM HILLIG M OSHAUGHNESSY JA POPLACK DG COWAN KH
Citation: Sl. Berg et al., PHARMACOKINETICS OF PIROXANTRONE IN A PHASE-I TRIAL OF PIROXANTRONE AND GRANULOCYTE-COLONY-STIMULATING FACTOR, Cancer research, 53(11), 1993, pp. 2587-2590
Risultati: 1-10 |